Deepull

Direct-from-blood multiplex PCR targeting 95% of sepsis-causing pathogens

Barcelona, Spain · Founded 2020 · $73.5M raised

Headquarters
Barcelona
Founded
2020
Business Model
B2B
Total Funding
$73.5M
Last Round
$58.3M Series CApr 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Deepull is a Barcelona, Spain-based clinical diagnostics company developing the UllCORE System, a direct-from-blood multiplex PCR platform that identifies sepsis-causing pathogens and antibiotic resistance markers in about one hour, targeting 95% of causative organisms. Led by CEO Jordi Carrera, the company aims to close the diagnostic gap in sepsis care where traditional blood culture testing can take days, and its UllCORE BSI Test has received FDA Breakthrough Device Designation.

Summary

Deepull is a Biotech company based in Barcelona, Spain, founded in 2020. It has raised $73.5M in total across 2 rounds, most recently a $58.3M Series C round in Apr 2025. Investors include Columbus Venture Partners, Panakes Partners and Mérieux Equity Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CApr 2025
$58.3M

Sign up to see all 2 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Deepull on Indexed.vc
<a href="https://indexed.vc/companies/deepull"><img src="https://indexed.vc/api/badge/company/deepull" alt="Deepull on Indexed.vc" width="260" height="76" /></a>